02/17/2021
5:10 AM | Aspire Capital Fund, LLC (Filed by)
aTyr Pharma (Subject)
| Form SC 13G
| |
02/16/2021
10:21 AM | Alyeska Investment Group, L.P. (Filed by)
aTyr Pharma (Subject)
| Form SC 13G
| |
02/12/2021
12:17 PM | aTyr Pharma (Subject)
FEDERATED HERMES, INC. (Filed by)
| Form SC 13G/A
| |
02/09/2021
8:15 PM | aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2021
8:12 PM | aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2021
3:16 PM | aTyr Pharma (Filer)
| Form 424B5
| |
02/08/2021
7:18 PM | aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2021
7:13 PM | aTyr Pharma (Issuer)
DENYES NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2021
7:08 PM | aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2021
9:15 AM | aTyr Pharma (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
|
01/25/2021
7:05 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2021
7:05 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2021
7:05 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2021
8:01 PM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2021
3:20 PM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/23/2020
11:15 PM | aTyr Pharma (Filer)
| Form EFFECT
| |
11/13/2020
4:24 PM | aTyr Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/02/2020
4:11 PM | aTyr Pharma (Filer)
| Form 424B3
| |
09/28/2020
11:15 PM | aTyr Pharma (Filer)
| Form EFFECT
| |
09/18/2020
3:26 PM | aTyr Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/14/2020
7:05 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2020
8:47 PM | aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2020
8:09 PM | aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2020
3:40 PM | aTyr Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2020
3:05 PM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2020
3:27 PM | aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2020
8:00 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2020
7:26 PM | aTyr Pharma (Issuer)
DENYES NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2020
7:22 PM | aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2020
7:17 PM | aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2020
7:13 PM | aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
3:19 PM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2020
3:16 PM | aTyr Pharma (Filer)
| Form 424B5
| |
05/12/2020
4:06 PM | aTyr Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2020
4:14 PM | aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2020
4:08 PM | aTyr Pharma (Issuer)
Lucas Svetlana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2020
7:35 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2020
3:16 PM | aTyr Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/18/2020
4:13 PM | aTyr Pharma (Filer)
| Form PRE 14A
| |
02/28/2020
4:16 PM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2020
1:46 PM | Altium Capital Management LP (Filed by)
aTyr Pharma (Subject)
| Form SC 13G
| |
02/12/2020
1:41 PM | aTyr Pharma (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SC 13G
| |
02/11/2020
12:27 PM | aTyr Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A
| |
02/11/2020
10:58 AM | aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2020
6:37 PM | aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2020
6:34 PM | aTyr Pharma (Issuer)
DENYES NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2020
6:30 PM | aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2020
4:31 PM | aTyr Pharma (Filer)
| Form 424B4
| |
02/05/2020
11:15 PM | aTyr Pharma (Filer)
| Form EFFECT
| |
02/05/2020
8:53 PM | aTyr Pharma (Filer)
| Form POS EX
| |
02/05/2020
8:48 PM | aTyr Pharma (Filer)
| Form S-1MEF
| |
02/03/2020
7:01 AM | aTyr Pharma (Filer)
| Form S-1/A
| |
01/27/2020
7:03 AM | aTyr Pharma (Filer)
| Form S-1/A
| |
01/17/2020
7:03 AM | aTyr Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/14/2020
4:28 PM | Alta Partners VIII, L.P. (Filed by)
aTyr Pharma (Subject)
| Form SC 13G/A
| |
01/06/2020
8:05 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2019
7:10 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2019
3:05 PM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2019
8:46 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2019
3:44 PM | aTyr Pharma (Subject)
Polaris Venture Partners V, L.P. (Filed by)
| Form SC 13D/A
| |
07/10/2019
1:58 PM | aTyr Pharma (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
07/02/2019
4:11 PM | aTyr Pharma (Issuer)
Lucas Svetlana (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/02/2019
4:09 PM | aTyr Pharma (Issuer)
Gross Jane A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/01/2019
8:00 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2019
3:15 PM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2019
11:15 PM | aTyr Pharma (Filer)
| Form EFFECT
| |
06/18/2019
4:28 PM | aTyr Pharma (Filer)
| Form S-3/A
| |
06/10/2019
10:51 AM | aTyr Pharma (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
05/21/2019
8:56 PM | aTyr Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/21/2019
7:45 PM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2019
7:43 PM | aTyr Pharma (Filer)
| Form 424B5
| |
05/20/2019
3:38 PM | aTyr Pharma (Issuer)
Krueger Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2019
8:00 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2019
3:15 PM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2019
6:40 PM | aTyr Pharma (Issuer)
BLAIR JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2019
4:35 PM | aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2019
4:29 PM | aTyr Pharma (Issuer)
MENDLEIN JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2019
4:22 PM | aTyr Pharma (Issuer)
Hatfield Jeffrey S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2019
4:06 PM | aTyr Pharma (Issuer)
Coughlin Timothy P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2019
4:01 PM | aTyr Pharma (Issuer)
CLARKE JOHN K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2019
3:11 PM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2019
1:42 PM | aTyr Pharma (Subject)
FEDERATED INVESTORS INC /PA/ (Filed by)
| Form SC 13G
| |
04/16/2019
3:57 PM | aTyr Pharma (Subject)
SCHIMMEL PAUL (Filed by)
| Form SC 13D/A
| |
04/16/2019
3:31 PM | aTyr Pharma (Issuer)
SCHIMMEL PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2019
7:30 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2019
7:16 AM | aTyr Pharma (Filer)
| Form 424B5
| |
03/28/2019
3:15 PM | aTyr Pharma (Filer)
| Form DEFA14A
| |
03/28/2019
3:12 PM | aTyr Pharma (Filer)
| Form DEFA14A
| |
03/28/2019
3:00 PM | aTyr Pharma (Filer)
| Form DEF 14A
| |
03/26/2019
4:28 PM | aTyr Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2019
3:15 PM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2019
8:00 AM | aTyr Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2019
3:59 PM | aTyr Pharma (Filer)
| Form PRE 14A
| |
02/12/2019
3:30 PM | Alta Partners VIII, L.P. (Filed by)
aTyr Pharma (Subject)
| Form SC 13G/A
| |
02/08/2019
7:12 PM | aTyr Pharma (Issuer)
Krueger Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
7:06 PM | aTyr Pharma (Issuer)
Krueger Nancy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2019
6:16 PM | aTyr Pharma (Issuer)
Broadfoot Jill Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
6:09 PM | aTyr Pharma (Issuer)
Shukla Sanjay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2019
4:18 PM | aTyr Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A
| |
12/26/2018
3:15 PM | aTyr Pharma (Issuer)
MENDLEIN JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
